These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15867173

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T, Kawasaki T, Miyai N, Kamitani T, Kawasaki S, Sugihara H.
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [Abstract] [Full Text] [Related]

  • 23. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F.
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [Abstract] [Full Text] [Related]

  • 24. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R, Cinca J, Bayes-Genis A, Pascual D, Fernandez-Palomeque C, Bardaji A, Almendral J, Nieto V, Macaya C, Jimenez RP, de Luna AB, Muerte Subita En La Insuficiencia Cardiaca (MUSIC) Group.
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [Abstract] [Full Text] [Related]

  • 25. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2007 May 22; 115(20):2637-41. PubMed ID: 17485579
    [Abstract] [Full Text] [Related]

  • 26. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, PainFREE Rx II Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):310-6. PubMed ID: 16022960
    [Abstract] [Full Text] [Related]

  • 27. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193
    [Abstract] [Full Text] [Related]

  • 28. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG.
    J Card Fail; 2008 Oct 10; 14(8):670-5. PubMed ID: 18926439
    [Abstract] [Full Text] [Related]

  • 29. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ, Raja SG, Salhiyyah K, Nagarajan K.
    Interact Cardiovasc Thorac Surg; 2008 Dec 10; 7(6):1141-6. PubMed ID: 18541605
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.
    J Med Assoc Thai; 2007 Jul 10; 90(7):1458-66. PubMed ID: 17710992
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy.
    Tomlinson DR, Bashir Y, Betts TR, Rajappan K.
    Europace; 2009 May 10; 11(5):638-42. PubMed ID: 19174376
    [Abstract] [Full Text] [Related]

  • 36. Left ventricular conduction delays induced by right ventricular apical pacing: effect of left ventricular dysfunction and bundle branch block.
    Varma N.
    J Cardiovasc Electrophysiol; 2008 Feb 10; 19(2):114-22. PubMed ID: 17971145
    [Abstract] [Full Text] [Related]

  • 37. Value of prolonged QRS duration as a predictor of low cardiac output syndrome in patients with impaired left ventricular systolic function who undergo isolated coronary artery bypass grafting.
    Açil T, Türköz R, Açil M, Sezgin AT, Baltali M, Gülcan O, Ozin B, Müderrisoğlu H.
    Am J Cardiol; 2006 Nov 15; 98(10):1357-62. PubMed ID: 17134629
    [Abstract] [Full Text] [Related]

  • 38. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A, El-Saed A, Voigt A, Albany C, Saba S.
    Pacing Clin Electrophysiol; 2008 May 15; 31(5):575-9. PubMed ID: 18439171
    [Abstract] [Full Text] [Related]

  • 39. QRS duration and late mortality in unselected post-infarction patients of the revascularization era.
    Bauer A, Watanabe MA, Barthel P, Schneider R, Ulm K, Schmidt G.
    Eur Heart J; 2006 Feb 15; 27(4):427-33. PubMed ID: 16338936
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.